BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.413
EU - Europa 791
AS - Asia 389
SA - Sud America 11
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.401
SE - Svezia 281
HK - Hong Kong 280
GB - Regno Unito 114
BG - Bulgaria 90
IT - Italia 83
DE - Germania 72
CN - Cina 66
FI - Finlandia 32
BE - Belgio 22
IE - Irlanda 19
FR - Francia 18
CA - Canada 12
UA - Ucraina 11
AT - Austria 10
IR - Iran 8
MY - Malesia 7
TR - Turchia 7
NL - Olanda 6
VN - Vietnam 6
CL - Cile 5
JP - Giappone 5
NO - Norvegia 5
RO - Romania 5
BR - Brasile 4
EG - Egitto 4
ES - Italia 4
PL - Polonia 4
RU - Federazione Russa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
IN - India 3
AU - Australia 2
BY - Bielorussia 2
MD - Moldavia 2
PK - Pakistan 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CH - Svizzera 1
CO - Colombia 1
GR - Grecia 1
HU - Ungheria 1
KZ - Kazakistan 1
PE - Perù 1
TN - Tunisia 1
Totale 4.614
Salva come PNG Salva come JPEG
Città #
Fairfield 552
Chandler 548
Ashburn 339
Hong Kong 279
Nyköping 255
Woodbridge 207
Houston 191
Wilmington 188
Cambridge 158
Seattle 157
Ann Arbor 147
San Diego 111
Princeton 90
Sofia 90
Southend 41
Bremen 33
Helsinki 31
Dearborn 28
London 26
New York 24
Brussels 22
Beijing 21
Dublin 18
Shanghai 13
Norwalk 11
Bologna 10
Jacksonville 9
Kilburn 9
Toronto 9
Vienna 9
Des Moines 8
Milan 7
Modena 7
Augusta 6
Chiswick 6
Dong Ket 6
Eugene 6
Grafing 6
Izmir 6
Rome 6
San Mateo 6
Leawood 5
Paris 5
Redwood City 5
San Francisco 5
Amsterdam 4
Fremont 4
Duncan 3
Falls Church 3
Hefei 3
Kunming 3
Phoenix 3
Prescot 3
Turin 3
Ardabil 2
Berlin 2
Boardman 2
Chengdu 2
Chisinau 2
Costigliole Saluzzo 2
Florence 2
Hiroshima 2
Hounslow 2
Islington 2
Jinan 2
Minsk 2
Montegranaro 2
Nanjing 2
Oslo 2
Romainville 2
Saint Louis 2
Tokyo 2
Trento 2
Acton 1
Almaty 1
Almere Stad 1
Andover 1
Boston 1
Brasov 1
Brierley Hill 1
Budapest 1
Cairo 1
Cesano Maderno 1
Charleston 1
Charlotte 1
Chicago 1
Ciampino 1
Clearwater 1
Como 1
Cordovado 1
Cupertino 1
Dallas 1
Dhaka 1
Dubai 1
Formigine 1
Frankfurt am Main 1
Göteborg 1
Hokkaido 1
Hunedoara 1
Iasi 1
Totale 3.810
Salva come PNG Salva come JPEG
Nome #
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 209
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 183
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation 160
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 159
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 125
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 122
Adaptive response in Hepatitis B virus infection 82
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 70
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 70
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 69
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 66
Chronic hepatitis B: Are we close to a cure? 64
Liver transplantation for patients with alcoholic liver disease: an open question 63
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 63
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 61
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 61
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 61
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 60
Stem cell mobilization and collection in patients with liver cirrhosis 60
Hepatitis B virus and immune response 59
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 59
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 58
Alcohol and viral hepatitis: a mini-review 58
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 56
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 55
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 55
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 54
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma 54
CD 133+ stem cells for the treatment of end stage liver disease 53
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 53
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis 53
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 51
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 51
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 51
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 50
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 50
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection 49
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study 49
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 49
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study 49
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 49
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 48
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 48
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 48
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 47
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen 47
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 46
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection 46
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 45
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 45
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 45
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 45
Bone marrow derived stem cells for the treatment of end-stage liver disease 45
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 44
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver 44
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 43
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B 43
Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors 43
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 42
Vitamins in the treatment of chronic viral hepatitis 41
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 41
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 40
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis 39
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance 38
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 38
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 37
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 37
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 37
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection 35
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin 35
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis 34
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 33
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C 32
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 32
Stem cells for end stage liver disease: How far have we got? 32
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 31
Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma 31
Trattamento dell’epatopatia alcolica 30
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 30
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 28
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 25
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 24
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 24
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS 23
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS) 23
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA 22
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection 21
MARS and Prometheus: our clinical experience in acute chronic liver failure 20
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma 19
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 17
Totale 4.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.610
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201971 0 0 0 0 0 0 0 0 0 6 19 46
2019/2020288 12 21 10 20 30 46 56 34 27 9 18 5
2020/2021860 17 10 10 20 15 31 10 20 396 30 272 29
2021/20221.484 257 134 48 25 11 86 90 85 207 185 193 163
2022/20231.378 188 174 101 137 160 225 11 126 174 4 44 34
2023/2024633 26 47 33 79 217 22 44 122 28 15 0 0
Totale 4.736